Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Cambria Investment Management L.P. Acquires 10,450 Shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP)
09:32am, Wednesday, 11'th Mar 2020
Cambria Investment Management L.P. increased its holdings in Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) by 55.6% in the 4th quarter, according to the company in its most recent Form 13F filing
Corbus Pharmaceuticals (NASDAQ:CRBP) Rating Lowered to Hold at Zacks Investment Research
07:58am, Wednesday, 11'th Mar 2020
Corbus Pharmaceuticals (NASDAQ:CRBP) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Monday, Zacks.com reports. According to
Corbus Pharmaceuticals appoints Pete Salzmann to board of directors CRBP;IMVT
01:22pm, Tuesday, 10'th Mar 2020
Corbus Pharmaceuticals appoints Pete Salzmann to board of directors CRBP IMVT
Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director
12:05pm, Tuesday, 10'th Mar 2020
Dr. Salzmann brings 20 years of industry experience and currently serves as Chief Executive Officer of Immunovant (IMVT), a biopharmaceutical company focused on developing therapies for patients with
Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director
12:05pm, Tuesday, 10'th Mar 2020
Norwood, MA, March 10, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug...
Did Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Insiders Buy Up More Shares?
11:14am, Tuesday, 10'th Mar 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Corbus Pharmaceuticals (CRBP) Set to Announce Quarterly Earnings on Thursday
07:32am, Tuesday, 10'th Mar 2020
Corbus Pharmaceuticals (NASDAQ:CRBP) is set to announce its earnings results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of ($0.34) per share for
